Abstract
These unique agents may be the answer when other treatments fail or are intolerable for patients with asthma, atopic dermatitis, hyperlipidemia, osteoporosis, or migraine headaches.
Cite
CITATION STYLE
APA
Campbell, L. S., & Sbar, E. D. (2022). Would your patient benefit from a monoclonal antibody? The Journal of Family Practice, 71(8). https://doi.org/10.12788/jfp.0481
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free